pyroglutamic acid
Small moleculeexperimental
Clinical trial activity
7 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
1
Earliest trial started Jan 1, 2001 (NCT00040456)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetSupplementation
supplementation
Chemistry & pharmacology
Loading structure…
SMILES
O=C1CC[C@@H](C(=O)O)N1- Mol. weight
- 129.12 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL397976 ↗
- ChEMBLCHEMBL3707303 ↗
Also known as
- (−)-2-pyrrolidone-5-carboxylic acid
- (−)-2-pyrrolidone-5-carboxylic acid
- glutimic acid
- glutimic acid
- l-5-pyrrolidone-2-carboxylic acid
- l-5-pyrrolidone-2-carboxylic acid
- l-pyroglutamic acid
- l-pyroglutamic acid
- l-pyrrolidone carboxylic acid
- l-pyrrolidone carboxylic acid
- magnesium pidolate
- magnesium pidolate
- magnesium pidolate
- magnesium pidolate
- magnesium pidolate
- magnesium pidolate
- pca
- pca
- pidolic acid
- pidolic acid
- pidolic acid
- pidolic acid magnesium salt
- pyroglutamic acid
- pyroglutamic acid
- pyroglutamic acid
- (s)-(−)-2-pyrrolidone-5-carboxylic acid
- (s)-(−)-2-pyrrolidone-5-carboxylic acid
- (s)-pyroglutamic acid
- (s)-pyroglutamic acid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05374343 | Phase 1 | May 5, 2022 | Sichuan University, Sunshine Lake Pharma Co., Ltd. |
| NCT05427682 | Phase 1 | Apr 19, 2022 | Sunshine Lake Pharma Co., Ltd. |
| NCT05109078 | Phase 1 | Dec 31, 2021 | Soochow University, Sunshine Lake Pharma Co., Ltd. |
| NCT01181830 | Phase 4 | Feb 1, 2010 | University of Verona |
| NCT00532883 | Phase 2 | Jan 1, 2007 | National Heart, Lung, and Blood Institute (NHLBI), St. Jude Children's Hospital |
| NCT00143572 | Phase 1 | Nov 1, 2004 | St. Jude Children's Hospital |
| NCT00040456 | Phase 2 | Jan 1, 2001 | Baylor University, Harvard University |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sunshine Lake Pharma Co., Ltd. | For profit | 3 | 3 | 1 | 2021 |
| St. Jude Children's Hospital | Academic/Hospital | 2 | 2 | 2 | 2004 |
| Baylor University | Academic/Hospital | 1 | 1 | 1 | 2001 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2001 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 0 | 1 | 2007 |
| Sichuan University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Soochow University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Verona | Academic/Hospital | 1 | 1 | 1 | 2010 |
8 organizations
Page 1 / 1